Pure Global

Bordetella pertussis IgM - India CDSCO Medical Device Registration

Bordetella pertussis IgM is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001078_5e926e63f3032ad8b987bbb7f75d58a8_db4dbdcc634339bc3c5e1aabc7cddb26. This device is marketed under the brand name NovaLisa®. The license holder is OSB Agencies Private Limiated, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Bordetella pertussis IgM
UID: IMP/IVD/2020/001078_5e926e63f3032ad8b987bbb7f75d58a8_db4dbdcc634339bc3c5e1aabc7cddb26

Brand Name

NovaLisa®

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Bordetella pertussis IgM ELISA is intended for the qualitative determination of IgM class antibodies against Bordetella pertussis in human serum or plasma (NovaLisa®)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing